|
業務類別
|
Biotechnology |
|
業務概覽
|
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors. |
| 公司地址
| 800 Bridge Parkway, Redwood, CA, USA, 94065 |
| 電話號碼
| +1 240 327-0603 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.arcellx.com |
| 員工數量
| 209 |
| Mr. Rami Elghandour |
President, Chief Executive Officer and Chairman of the Board |
美元 653.29K |
26/02/2026 |
| Dr. Christopher Heery, M.D. |
Chief Medical Officer |
美元 480.96K |
17/04/2025 |
| Ms. Michelle Gilson |
Chief Financial Officer and Principal Accounting Officer |
美元 475.96K |
26/02/2026 |
|
|
| Ms. Olivia C. Ware, M.B.A. |
Independent Director |
26/02/2026 |
| Mr. David Charles Lubner, C.P.A.,M.S. |
Independent Director |
26/02/2026 |
| Ms. Jill Carroll, M.S. |
Independent Director |
26/02/2026 |
| Mr. Rami Elghandour |
President, Chief Executive Officer and Chairman of the Board |
26/02/2026 |
| Dr. Ali Behbahani, M.B.A.,M.D. |
Independent Director |
26/02/2026 |
| Dr. Kavita K. Patel, M.D. |
Independent Director |
26/02/2026 |
| Mr. Andrew H. Galligan |
Director |
26/02/2026 |
| Ms. Kristin Myers |
Director |
26/02/2026 |
|
|
|
|
